Cargando…
Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis
BACKGROUND: During the COVID-19 period, there was a huge gap in the understanding of masks between east and west. At the same time, the mechanism of the mask and the effect after use, also appeared differences. The Objective of this Meta-analysis is to systematically evaluate the efficacy of masks f...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220057/ https://www.ncbi.nlm.nih.gov/pubmed/32384507 http://dx.doi.org/10.1097/MD.0000000000020160 |
_version_ | 1783533079026991104 |
---|---|
author | Chen, Mao-bing Wang, Hua Zheng, Qi-han Cui, Wei-yan Xu, Hua-lan Zheng, Xu-wen |
author_facet | Chen, Mao-bing Wang, Hua Zheng, Qi-han Cui, Wei-yan Xu, Hua-lan Zheng, Xu-wen |
author_sort | Chen, Mao-bing |
collection | PubMed |
description | BACKGROUND: During the COVID-19 period, there was a huge gap in the understanding of masks between east and west. At the same time, the mechanism of the mask and the effect after use, also appeared differences. The Objective of this Meta-analysis is to systematically evaluate the efficacy of masks for influenza in the community. METHODS: The Web of Science, PubMed, The Cochrane Library, EMBASE and Clinical Trials will be electronically searched to collect randomized controlled trials regarding the efficacy of masks for influenza in the community through Apr 2020. Two researchers independently screened and evaluated the obtained studies and extracted the outcome indexes. Revman 5.3 software will be used for the meta-analysis. RESULTS: The outbreak is continuing, and we need to be prepared for a long fight. If masks are effective, we need to promote their use as soon as possible. If masks are ineffective, strong evidence should be given. This is an urgent task and our team will finish it as soon as possible. CONCLUSION: Provide stronger evidence to solve the problem, should we wear masks or not right now. |
format | Online Article Text |
id | pubmed-7220057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-72200572020-06-15 Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis Chen, Mao-bing Wang, Hua Zheng, Qi-han Cui, Wei-yan Xu, Hua-lan Zheng, Xu-wen Medicine (Baltimore) 4900 BACKGROUND: During the COVID-19 period, there was a huge gap in the understanding of masks between east and west. At the same time, the mechanism of the mask and the effect after use, also appeared differences. The Objective of this Meta-analysis is to systematically evaluate the efficacy of masks for influenza in the community. METHODS: The Web of Science, PubMed, The Cochrane Library, EMBASE and Clinical Trials will be electronically searched to collect randomized controlled trials regarding the efficacy of masks for influenza in the community through Apr 2020. Two researchers independently screened and evaluated the obtained studies and extracted the outcome indexes. Revman 5.3 software will be used for the meta-analysis. RESULTS: The outbreak is continuing, and we need to be prepared for a long fight. If masks are effective, we need to promote their use as soon as possible. If masks are ineffective, strong evidence should be given. This is an urgent task and our team will finish it as soon as possible. CONCLUSION: Provide stronger evidence to solve the problem, should we wear masks or not right now. Wolters Kluwer Health 2020-05-08 /pmc/articles/PMC7220057/ /pubmed/32384507 http://dx.doi.org/10.1097/MD.0000000000020160 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 4900 Chen, Mao-bing Wang, Hua Zheng, Qi-han Cui, Wei-yan Xu, Hua-lan Zheng, Xu-wen Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis |
title | Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis |
title_full | Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis |
title_fullStr | Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis |
title_full_unstemmed | Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis |
title_short | Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis |
title_sort | comparative efficacy of the front-line anti-hbv drugs in nucleos(t)ide analogue-naive chronic hepatitis b: a protocol for systematic review and network meta-analysis |
topic | 4900 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220057/ https://www.ncbi.nlm.nih.gov/pubmed/32384507 http://dx.doi.org/10.1097/MD.0000000000020160 |
work_keys_str_mv | AT chenmaobing comparativeefficacyofthefrontlineantihbvdrugsinnucleostideanaloguenaivechronichepatitisbaprotocolforsystematicreviewandnetworkmetaanalysis AT wanghua comparativeefficacyofthefrontlineantihbvdrugsinnucleostideanaloguenaivechronichepatitisbaprotocolforsystematicreviewandnetworkmetaanalysis AT zhengqihan comparativeefficacyofthefrontlineantihbvdrugsinnucleostideanaloguenaivechronichepatitisbaprotocolforsystematicreviewandnetworkmetaanalysis AT cuiweiyan comparativeefficacyofthefrontlineantihbvdrugsinnucleostideanaloguenaivechronichepatitisbaprotocolforsystematicreviewandnetworkmetaanalysis AT xuhualan comparativeefficacyofthefrontlineantihbvdrugsinnucleostideanaloguenaivechronichepatitisbaprotocolforsystematicreviewandnetworkmetaanalysis AT zhengxuwen comparativeefficacyofthefrontlineantihbvdrugsinnucleostideanaloguenaivechronichepatitisbaprotocolforsystematicreviewandnetworkmetaanalysis |